Previous 10 | Next 10 |
San Diego - ( NewMediaWire ) - March 8, 2021 - Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of life-threatening inflammatory conditions precipitated by Cytokine Storm Syndrome (the Cytokine Storm), today announced that Jim Joyce, its ...
SAN DIEGO, March 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of life-threatening inflammatory conditions precipitated by Cytokine Storm Syndrome (the Cytokine Storm), today announ...
San Diego, CA - ( NewMediaWire ) - February 11, 2021 - Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of life-threatening inflammatory conditions precipitated by Cytokine Storm Syndrome (the Cytokine Storm), announced today that its Chairma...
Mr. Lynam to Oversee Clinical Studies of Sigyn Therapy™ to Treat Life-Threatening Inflammatory Conditions San Diego, CA - ( NewMediaWire ) - January 26, 2021 - Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of...
SAN DIEGO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), disclosed today that its Chairman and CEO Jim Joyce is featured in an interview with The Wall Street Analyzer. During the interview, Mr. Joyce discusses recent data-dr...
SAN DIEGO, Jan. 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), today released the following note authored by its Chairman and CEO, Jim Joyce. Dear Current and Candidate Shareholders, We created Sigyn Therapy to address a signi...
Sigyn Therapy™ is a Candidate to Treat Life-Threatening Inflammatory Conditions That Are Not Addressed with Drug Therapies SAN DIEGO, Jan. 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company ...
Sigyn Therapy™ is a Candidate to Treat Sepsis and Other Life-Threatening Inflammatory Conditions That Are Not Addressed with Approved Drugs SAN DIEGO, CA - ( NewMediaWire ) - December 01, 2020 - Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused...
Sigyn Therapy™ is a Candidate to Treat Sepsis and Other Life-Threatening Inflammatory Conditions That Are Not Addressed with Approved Drugs SAN DIEGO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical techno...
San Diego, CA - ( NewMediaWire ) - November 02, 2020 - Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), today released the following note authored by its Chairman and CEO, Jim Joyce. Dear Current and Candidate Shareholders, We created Sigyn Therapy™ to add...
News, Short Squeeze, Breakout and More Instantly...
Sigyn Therapeutics Company Name:
RGNP Stock Symbol:
OTCMKTS Market:
SAN DIEGO, CA, July 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of sepsis and other life-threatening inflammatory conditions, today announced the completion of a study that demo...
SAN DIEGO, July 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of sepsis and other life-threatening inflammatory conditions, today announced the completion of an invitro blood pu...
Webinar Event to Be Held Tomorrow June 29th at 12pm Eastern / 9am Pacific Time SAN DIEGO, CA, June 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of sepsis and other life-t...